2013
DOI: 10.1055/s-0033-1343791
|View full text |Cite
|
Sign up to set email alerts
|

Antiviral-Resistant Fulminant Herpes Hepatitis in Pregnancy

Abstract: Fulminant herpes hepatitis with disseminated extrahepatic involvement in pregnancy is rare and carries a high mortality risk. Although acyclovir remains standard first-line therapy, effective management of acyclovir-resistant disseminated herpes simplex virus (HSV) in pregnancy remains elusive. We present a case of disseminated HSV resistant to both acyclovir and foscarnet, the first double-agent resistant case in pregnancy reported in the literature to date. In this case, therapeutic delivery was the ultimate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 19 publications
0
3
0
Order By: Relevance
“…While the patients in case 1 and 3 had near complete resolution of hepatitis within 5 days of initiation of acyclovir, unfortunately case 2 had rapid progression to fulminant hepatic failure and death, possibly because her disease burden was already too great on presentation or that the virus was acyclovir resistant. Though data is sparse, intravenous foscarnet is the agent of choice in cases of acyclovir-resistant herpetic infection; however even dual-agent therapy has proven ineffective in preventing mortality in previous case reports [ 9 ]. In general, the data also suggest that acyclovir should be started empirically for high-risk patients with ALF of unknown etiology, pending laboratory confirmation of the diagnosis.…”
Section: Discussion and Literature Reviewmentioning
confidence: 99%
“…While the patients in case 1 and 3 had near complete resolution of hepatitis within 5 days of initiation of acyclovir, unfortunately case 2 had rapid progression to fulminant hepatic failure and death, possibly because her disease burden was already too great on presentation or that the virus was acyclovir resistant. Though data is sparse, intravenous foscarnet is the agent of choice in cases of acyclovir-resistant herpetic infection; however even dual-agent therapy has proven ineffective in preventing mortality in previous case reports [ 9 ]. In general, the data also suggest that acyclovir should be started empirically for high-risk patients with ALF of unknown etiology, pending laboratory confirmation of the diagnosis.…”
Section: Discussion and Literature Reviewmentioning
confidence: 99%
“…Abdominal pain combined with fever and hepatic dysfunction in pregnancy should prompt immediate consideration of the diagnosis of herpes hepatitis. 25 Laboratory analysis typically reveals elevated liver transaminases (up to 100 times the upper limit of normal), normal or mildly elevated bilirubin, leukopenia, and coagulopathy. Our patient’s pattern of liver injury, as well as her leukopenia and mild coagulopathy was consistent with this picture.…”
Section: Discussionmentioning
confidence: 99%
“…28 Serial HSV PCR levels can be measured to determine the magnitude of viremia and to detect resistance. 25 In the case of drug-resistant HSV infection, intravenous foscarnet can be considered, although it carries a significant risk of toxicity to the renal tubules and should be used only when there is high risk of mortality. 29 In cases of acute liver failure, liver transplantation should be considered early and immediate transfer to a liver transplant center is warranted.…”
Section: Discussionmentioning
confidence: 99%